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Osteoporosis (OP) is a multifactorial disease influenced by genetic factors in more than half of the cases. 
In spite of the efforts to clarify the relationship among genetic factors and susceptibility to develop 
OP, many genetic associations need to be further functionally validated. Besides, some limitations 
as the choice of stably expressed reference genes (RG) should be overcome to ensure the quality and 
reproducibility of gene expression assays. To our knowledge, a validation study for RG in OP is still 
missing. We compared the expression levels, using polymerase chain reaction quantitative real time 
(qPCR) of 10 RG (G6PD, B2M, GUSB, HSP90, EF1A, RPLP0, GAPDH, ACTB, 18 S and HPRT1) to assess 
their suitability in OP analysis by using GeNorm, Normfinder, BestKeeper and RefFinder programs. A 
minimal number of two RG was recommended by GeNorm to obtain a reliable normalization. RPLP0 
and B2M were identified as the most stable genes in OP studies while ACTB, 18 S and HPRT1 were 
inadequate for normalization in our data set. Moreover, we showed the dramatic effects of suboptimal 
RG choice on the quantification of a target gene, highlighting the importance in the identification of the 
most appropriate reference gene to specific diseases. We suggest the use of RPLP0 and B2M as the most 
stable reference genes while we do not recommend the use of the least stable reference genes HPRT1, 
18 S and ACTB in OP expression assays using PBMC as biological source. Additionally, we emphasize the 
importance of individualized and careful choice in software and reference genes selection.
Osteoporosis (OP) is a multifactorial disease, characterized by low bone mineral density (BMD) and loss of tissue 
microarchitecture1–3. The disease is influenced by genetic factors in around 50-85% of cases, especially in early 
or idiopathic OP1–4. The occurrence of fractures, the most important clinical manifestation of OP, shows herit-
ability estimated in the range of 25–68%, presenting the highest values for younger patients and fractures that 
occur before the age of 70 years1,5. Recent Genome-Wide Association Studies (GWAS) identified several genes 
associated with BMD variations and fractures risk, however these associations remain to be further functionally 
validated3,6,7.
Gene expression analyses performed by polymerase chain reaction quantitative real time (qPCR) is a sensitive, 
accurate and commonly used method in molecular biological studies8,9. In 2009, in view of resolving technical 
challenges and to standardize qPCR experiments, the Minimum Information for Publication of Quantitative 
Real-Time PCR experiments (MIQE) guidelines was published10. One of the points highlighted by those guide-
lines was the need of validating reference genes for specific tissues, thereby ensuring the efficiency and quality 
of gene expression assays10. Regardless of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and beta-actin 
(ACTB) being traditionally used as reference genes, it is necessary to choose constitutive and stably expressed 
genes for different tissues and different experimental conditions8,11.
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In spite of the efforts of Genetic Markers for Osteoporosis (GENOMOS) and Genetic Factors of Osteoporosis 
(GEFOS) consortiums to clarify the genetic factors involved in OP development, to our knowledge, none of the 
studies provided specific reference genes to be routinely used in OP gene expression assays. Therefore, we con-
ducted an evaluation of 10 candidate reference genes commonly used in previous studies of rheumatic diseases to 
establish a set of specific and validated reference genes for expression analysis in OP-related genes. To this end we 
considered the peripheral blood mononuclear cells (PBMC), one of the main tissues analyzed in clinical-related 
studies in OP aiming to contribute to the advance of gene expression studies in the field of bone research.
Results
Specificity and amplification efficiencies. Specificity of the primers was verified by using agarose gel 
electrophoresis, in which a single band was detected, and the result confirmed by a single peak in the melting 
curve from qPCR analysis. The melting curves from all tested primers are shown in SM 1. The R2 and E values of 
the 10 candidate reference genes ranged from 0.999–1.000 and 95.12% − 104.79%, respectively (Table 1). These 
values were in accordance to the MIQE guidelines instructions.
Expression profile of candidate reference genes. The quantification cycle (Cq) was used to determine 
the expression level of candidate genes (SM 2). Among the OP patients’ group, the EF1A exhibited the highest 
expression levels (ranging from 18.620 to 18.908 Cq values) while HSP90 exhibited the highest expression levels 
in the healthy control group (ranging from 22.087 to 24.254 Cq values). In both groups, ACTB gene showed the 
lowest expression levels (ranging from 27.748 to 33.388 in patient’s group and from 26.395 to 41.410 in healthy 
control group). Regarding to standard deviations (SD) G6PD exhibited the lowest values to OP group (ranging 
from 0.874 to 6.233 SD values), while HPRT1 exhibited the lowest values in healthy control group (ranging from 
0.324 to 2.585) SD values. ACTB gene showed the highest SD values to both groups. Cq values and their variations 
can be appreciated in details in Fig. 1.
GeNorm analysis. In accordance to GeNorm ranking, generated from M values, RPLP0 and B2M were the 
most stable reference genes (M = 0.423) for the present study (Fig. 2A). The pairwise variations showed V2/V3 
exhibited the lowest pairwise value (0.053) (Fig. 2B). Thus, the minimal number of reference genes calculated by the 
algorithm and recommended to obtain a reliable normalization was two. In the present study, these genes are RPLP0 
and B2M. The HPRT1, 18 S, and ACTB showed the highest M values (M = 1.579, M = 1.959, M = 2.573, respectively).
NormFinder analysis. The NormFinder software generated a ranking, in which RPLP0 (M = 0.460) exhibited 
the lowest variation values, being considered the most stably expressed gene, followed by EF1A (M = 0.599) (Fig. 2C). 
The most stable combination of genes was between both genes abovementioned (M = 0.562). The candidate reference 
genes showing the highest variation values were ACTB (M = 2.631), 18 S (M = 1.874) and HPRT1 (M = 1.065) (Fig. 2C).
BestKeeper analysis. Based on SD, HSP90 presented the lowest variation value (SD [±CP] = 0.91; SD 
[±x-fold] = 1.87), while ACTB exhibited the highest variation value (SD [±CP] = 4.87; SD [±x-fold] = 29.15). 
Based on the correlation coefficient (r), the best reference gene was RPLP0 (r = 0.987; p = 0.001) followed by 
EF1A (r = 0.975; p = 0.001). The lowest correlation coefficient (r) was observed to HPRT1 (r = 0.606; p = 0.064) 
followed by ACTB (r = 0.695; p = 0.026) and 18 S (r = 0.721; p = 0.019) (Fig. 2D). When both the correlation 
coefficient (r) and the SD were considered, the HSP90 was not one of the top-ranked genes due to its lowest cor-
relation coefficient (r = 0.797; p = 0.006).
Name Gene Protein function Primer sequences/Taqman® probe reference Product size/bp R2 E/%
G6PD Glucose-6-phosphate 1-dehydrogenase fatty acid and nucleic acid synthesis F: CCGTGATGAGAAGGTCAAGGT R: TACTGGCCCAGGACCACATT 72 0.999 95.12
B2M Beta-2-microglobulin small subunit of the MHC1 F: TGAGTGGCATGAAGAAGGTGT R: GGCAGTTCTTTGCCCTCTCT 77 0.999 104.79
GUSB Beta-glucuronidase degradation of dermatan and keratan sulfates F: CACTGTGGCTGTCACCAAGA R: TCCGCATCCTCATGCTTGTT 84 1 100.51
HSP90 Heat shock protein HSP 90-beta regulation of proteins in cell cycle control and signal transduction.
F: GCCTACTTGGTGGCAGAGAA R: 
CAGCAGAAGACTCCCAAGCA 79 0.999 98.38
EF1A Elongation factor 1-alpha 1 protein synthesis F: GAGGCTGCTGAGATGGGAAA R: CGTTCACGCTCAGCTTTCAG 74 1 102.37
RPLP0 60 S acidic ribosomal protein P0 ribosomal protein lateral stalk subunit P0 F: GCGACCTGGAAGTCCAACTA R: TCTGCTTGGAGCCCACATTG 100 0.999 102.02
GAPDH Glyceraldehyde- 3-phosphate dehydrogenase glycolytic enzyme
F: CTGATGCCCCCATGTTCGT R: 
GCAGGAGGCATTGCTGATGA 80 0.999 96.81
ACTB Actin, cytoplasmic 1 cytoskeleton Hs 99999903_m1 171 1 100
18 S 18 S ribosomal ribosomal subunit Hs 03003631_g1 187 1 100
HPRT1 Hypoxanthine- guanine phosphoribosyltransfe- rase generation of purine nucleotides
F:ACAGGACTGAACGTCTTGCT R: 
GAGCACACAGAGGGCTACAA 74 0.99 101.43
IFNG Interferon gamma immunoregulation F: TCCAAGTGATGGCTGAACTGT R: TCGACCTCGAAACAGCATCT 77 1 99.45
Table 1. Primers and PCR efficiencies of the candidate reference and target genes used for OP samples.
3Scientific RepoRtS |         (2019) 9:16533  | https://doi.org/10.1038/s41598-019-52612-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
RefFinder analysis. The ranking performed by RefFinder analysis  and by the other above mentioned 
analyses performed in this work are shown in Table 2. According to RefFinder algorithm, RPLP0 (GM = 1.495) 
followed by B2M (GM = 2.449) were the better reference genes for OP studies using PBMC. Similarly to other uti-
lized analyses the ACTB (GM = 10), HPRT1 (GM = 8.485) and 18 S (GM = 8.485) were the least stable reference 
genes. In spite of the final ranking being similar to other studied algorithms, the individual results performed by 
RefFinder were substantially different from the original output provided by each program (Table 3).
Validation of candidate reference genes. In accordance to results from GeNorm analysis, two reference 
genes are enough to perform expression assays in this study. Thus, we chose the two most stable genes (RPLP0 
and B2M; RPLP0 and EF1A) to compare with the least stable (ACTB, 18 S and HPRT1) ones using IFNG expres-
sion analysis as reference. When RPLP0 and B2M were used for normalization, the analysis showed that IFNG 
was up-regulated (4.32 fold change) in OP patients with respect to the healthy control group. When RPLP0 and 
EF1A were used for normalization, the analysis showed that IFNG was up-regulated (3.53 fold change) in OP 
patients than healthy control group. On the other hand, when ACTB, 18 S and HPRT1 were used, the IFNG was 
up-regulated by only 2.06 fold change (FC) in OP patients with respect to the control healthy group.
In the analysis of each gene independently, the group of patients presented higher expression of IFNG than 
healthy control group when using the following reference genes: RPLP0 (4.56 FC), B2M (4.09 FC), EF1A (2.74 
FC), HPRT1 (2.12 FC) and 18 S (5.61 FC). Conversely, when using either ACTB as reference gene individually, the 
expression of IFNG was lower in the group of patients than in control group (−1.37 FC) (Fig. 3).
Discussion
In this study, we investigated the expression stability of the 10 most commonly used reference genes in rheumatic 
diseases using four statistical algorithms. To our knowledge, this is the first study to suggest the optimal reference 
genes for reliable expression analysis in OP using PBMC as biological source of RNA. The software used were 
GeNorm, NormFinder, BestKeeper and RefFinder, which are algorithms for reference gene evaluation widely 
accepted by the scientific community.
In spite of some differences exhibited among the software’s ranking from the four used programs, the results 
are relatively similar, especially in relation to the most and the least stable reference genes suggested. RPLP0 
was the most stable reference gene according to all used algorithms, followed by B2M (GeNorm and RefFinder) 
or EF1A (NormFinder and BestKepper). In accordance to the ranking above mentioned, the GeNorm showed 
a small difference in the most stable reference genes ranking in relation to NormFinder and BestKeeper. The 
Figure 1. Candidate reference genes expression levels from all samples (A), healthy group (B) and patients’ 
group (C) presented as the Cq mean. The boxes show the medians values (lines across the boxes), the one-
quarter (Q1) and the three-quarters (Q3) and the whisker caps indicating the minimum and maximum Cq 
values. The (X) represent the outliers’ values.
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Figure 2. Stability analysis as revealed using different software packages. (A) Candidate reference gene stability 
analyzed using GeNorm. Low M values predict high stability while high M values indicate low stability. (B) 
Pairwise variation (Vn/Vn + 1) to determine the optimal number of reference genes required for accurate 
normalization by GeNorm. In this OP study, the pairwise variation value less than the cut-off (0.15) is reached 
with two reference genes. (C) Candidate reference gene stability analyzed using NormFinder. Low M values 
predict higher stability. (D) Candidate reference gene stability analyzed using BestKeeper. High Pearson 
correlation coefficient (r) predicts high stability.
GeNorm NormFinder BestKeeper RefFinder
RPLPO/B2M RPLPO RPLPO RPLPO
GUSB EF1A EF1A B2M
EF1A B2M B2M G6PD
G6PD G6PD GAPDH EF1A
GAPDH GUSB GUSB GUSB
HSP90 HSP90 G6PD HSP90
HPRT1 GAPDH HSP90 GAPDH
18 S HPRT1 18 S HPRT1
ACTB 18 S ACTB 18 S
ACTB HPRT1 ACTB
Table 2. Reference genes rank from GeNorm, NormFinder, BestKeeper and RefFinder.
Method 1 2 3 4 5 6 7 8 9 10
Delta CT RPLP0 B2M GUSB EF1A G6PD GAPDH HSP90 18 S HPRT1 ACTB
BestKeeper HSP90 G6PD RPLP0 GUSB GAPDH B2M EF1A HPRT1 18 S ACTB
Normfinder B2M RPLP0 EF1A GAPDH GUSB G6PD HSP90 18 S HPRT1 ACTB
Genorm RPLP0/B2M GUSB EF1A G6PD GAPDH HSP90 HPRT1 18 S ACTB
Recommended 
comprehensive ranking RPLP0 B2M GUSB G6PD EF1A HSP90 GAPDH HPRT1 18 S ACTB
Table 3. Ranking Order (Better–Good–Average) showing the individual values of each software calculated by 
RefFinder.
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latest two programs are recognized as able to generate more reliable data since they are less sensitive towards 
co-regulation and differences among the primers efficiencies11,12. However, in our study the relative quantitation 
was corrected according to primers efficiency, additionally the candidate reference genes belonged to different 
functional groups, which helped to correct this deficiency from GeNorm. Similarly, the RefFinder also showed 
in its final rank RPLP0 and B2M as the best combination of reference genes. However, the calculated ranking by 
RefFinder were discrepant in relation to original results calculated by the programs individually, which probably 
occurred due to the fact that the program uses raw Cq values and did not accept corrections to reactions efficien-
cies (Table 3)12. Therefore, we do not recommend this software as a unique tool for the validation of reference 
genes as the output may be biased. On the other hand, the normalization factor analysis showed more similar 
values between RPLP0 and B2M than RPLP0 and EF1A. Thus, based on GeNorm output and this last analysis, we 
suggest the combination RPLP0 and B2M as the most stable for OP gene expression studies using PBMC.
RPLP0 encodes one out of approximately 80 ribosomal proteins in human, which are involved in protein 
synthesis and apoptosis processes13. In a previous study Ragni et al.14 classified the RPLP0 as the most stable ref-
erence gene in expression assays performed in mesenchymal stem cell differentiation, osteoblasts precursor cells. 
In addition, The second most stable gene, B2M, encodes β2-microglobulin, which has not been cited by GWAS as 
a potential gene involved in OP, however, previous studies related its association with bone metabolism in tumor 
processes15–17. In spite of that, similarly to our study, Stephens et al.18 and Li et al.19 showed B2M as the one of 
the most stable reference genes in expression analysis in mouse bone cells and mesenchymal stem cells cultures, 
respectively. It appears that the relation between bone system and B2M variation is more related to cancer cells 
than the health bone15,20.
In contrast, for the low stability analysis, all the programs showed the HPRT1, ACTB and 18 S as the three least 
stable reference genes. ACTB, as well as GAPDH, are used as internal controls in more than 70% of expression 
analyses performed by qPCR8,21. However, due to the very low stability in all used programs, ACTB was not rec-
ommended as reference gene for our analysis. ACTB gene encodes for β-actin, one of six different actin isoforms in 
vertebrates and is ubiquitously expressed in cell cytoplasm22,23. Actins compose the cytoskeleton, which plays crit-
ical roles in cell motility, structure, and integrity, besides acting in the regulation of gene expression23. Tai et al.24  
showed for the first time that the factor osteo-inductive simvastatin acts in the bone regeneration by increasing 
actin filament organization and cell rigidity. Similarly, Elsafadi et al.25 related the involvement of distribution of 
the actin filament and changes in cytoskeletal organization in the osteoblastic and adipocyte differentiation of 
stem cells (hMSC) in vitro. This novel role ascribed to beta actin is a possible explanation to variation of ACTB 
gene expression in OP samples, as the disease is strictly related to the balance between bone formation and 
resorption.
HPRT1 gene encodes for hypoxanthine-guanine phosphoribosyl transferase (HPRT), recognized by its trans-
ferase activity, able to catalyze purine bases guanine and hypoxanthine into their respective monophosphate 
nucleoside26. In spite of being acceptably stable in osteoblasts and osteoclasts18 and osteosarcoma20 cell culture 
studies, Yan et al.27 suggested that HPRT might regulate bone metabolism. The authors suggested that this protein 
might be involved in the development of osteoporosis through the transferase activity, which may contribute to 
the generation of free radical species and oxidative stress, affecting bone metabolism. Additionally, Isomura et al.28  
also showed in postmenopausal rats that oxidative stress could be involved in the OP pathogenesis.
18 S gene encodes for ribosome 18 S rRNA subunit and, to our knowledge, there is no study reporting altered 
expression levels of this gene or its protein in bone cells or diseases related to changes of bone mineral density. 
Nevertheless, several limitations have been described so far, for instance, 18 S expression levels being higher 
than the target gene29,30 and also the regulation of their transcription by biological and chemical agents31. These 
alterations, similarly to the other candidate genes in our analysis, are not in accordance to the criteria of constant 
level of the expression and the absence of influence by environmental factors required for an acceptable reference 
gene30. Besides, Ragni et al.14 and Stephens et al.18 considered the 18 S inadequate for normalization in osteogenic 
and chondrogenic differentiation and mouse osteoblasts and osteoclasts analysis, respectively.
The impact of using these reference genes might be visualized in the expression levels of the target gene, which 
ranged greatly when different reference genes combinations were used. The ACTB showed that IFNG was down 
Figure 3. Relative quantification of IFNG expression using the most (RPLP0, B2M and EF1A) and the least 
(ACTB, 18S and HPRT1) reference genes for normalization.
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regulated in OP patients group, while according to all the other analyzed genes the IFNG was up regulated in 
the same group. In addition, when the ACTB, 18 S, and HPRT1 reference genes are used in combination, anal-
ysis showed the level of IFNG expression in the patient group (2.06 FC) was less than half the expression levels 
reported using the RPLP0 genes and B2M combined (4.32 FC). The expression level provided by the combination 
of the least unstable genes was also lower than the value obtained with the combination RPLP0 and EF1A (3.53 
FC). It is also important to note that the combined relative expression (2.06 FC) changed the relative expression 
pattern provided by the individual genes (ACTB (−1.37 FC); 18 S (5.61 FC) and HPRT1 (2.12 FC)). The differ-
ence between the relative expression levels of IFNG when using the less stable genes in combination in relation 
to the individual standard of each gene, as well as the difference of the expression of these genes in relation to 
the more stable genes, proves the impact of the choice of the genes reference in expression analysis. These results 
highlight the importance in validating reference genes for specific tissues and diseases showing the aggravating 
effect of ACTB to be used in most expression analysis, which suggests that its validation has been often disre-
garded in expression studies8,10. The qPCR is a technique recognized by high sensitivity and sequence-specificity, 
however, the conclusions about the mRNA expression analysis may be useful only after appropriate reference 
gene selection10,30.
Methods
Subjects. We collected peripheral blood samples from ten postmenopausal osteoporotic women (mean age 
69 ± 9.71 years old) diagnosed according WHO criteria and from ten healthy controls (mean age 63 ± 3.16 years) 
in postmenopausal period and without any osteometabolic disease. Individuals with cancer, inflammatory and 
autoimmune diseases were excluded. The present study was approved by the Research Ethics Committee of the 
Center for Health Sciences, Federal University of Pernambuco (CEP/CCS/UFPE n° 513/11), performed accord-
ing the Declaration of Helsinki and all the participants who accepted to participate of this research provided a 
written informed consent.
RNA extraction and cDNA synthesis. Total RNA was extracted using TRIzol Reagent (Invitrogen, 
USA) according to the manufacturer’s instructions. The RNA integrity was verified by agarose gel electrophore-
sis and the quantification and RNA quality was checked by Nanodrop ND 1000 spectrophotometer (Nanodrop 
Technologies, USA). Samples that showed integrity of 23 S and 16 S fragments and the absorbance ratio 
OD260/280 values from 1.8 to 2.0 were considered able to proceed to the analysis. The cDNA synthesis was per-
formed from each RNA sample using GoScript™ Reverse Transcription System (Promega, USA) following the 
manufacturer’s instructions.
Selection of candidate reference genes and PCR primer design. The selection of candidate reference 
genes was performed by employing the most used reference genes from researchers in humans32,33. Besides, ref-
erence genes commonly used in rheumatic diseases were added to the analysis. A total of 10 genes were selected: 
glucose-6-phosphate dehydrogenase (G6PD), β2-microglobulin (B2M), β-glucuronidase (GUSB), heat shock 
protein 90 (HSP90), elongation factor 1 alpha (EF1A), ribosomal protein P0 (RPLP0), GAPDH, ACTB, 18 S ribo-
somal RNA (18 S) and hypoxanthine phosphoribosyltransferase 1 (HPRT1). All gene sequences were obtained 
from GenBank (www.ncbi.nlm.nih.gov/genbank/) and all primers were designed by NCBI/Primer-BLAST (www.
ncbi.nlm.nih.gov/tools/primer-blast/). For ACTB and 18 S we used Taqman probes. Sequence details are shown 
in Table 1.
Amplification efficiency testing. The efficiency value for each primer (E) was determined by slopes of 
standard curves from five 10-fold serial dilution points for each cDNA sample, starting with 5 ng of cDNA. The 
acceptable values were defined between 95% and 105%. For ACTB and 18 S (Taqman probes), we considered a 
reaction efficiency of 100% ensured by manufactures’ information.
Quantitative real-time PCR assay. The qPCR was performed on the ABI 7500 (Applied Biosystems, USA) 
platform using 5 ng of cDNA, 10 µM of each primer, 5 μL SYBR Green Master Mix (1×) (Thermo Fischer Scientific, 
USA) and ultrapure water to a final volume of 10 μL. The Taqman assays were performed following the manufac-
tures’ instructions. The melting curve was analyzed to confirm the specificities of the amplification reactions.
Data analysis of gene expression stability. Three statistical algorithms from Excel based free soft-
ware packages were used to evaluate the expression stability of 10 candidate reference genes to OP: GeNorm 
(Version v3.5)34, NormFinder (Version 20)35 and BestKeeper (Version 1)36. Additionally, the web-based online 
tool RefFinder37 and GeNorm were used to assist in the ranking and to calculate the optimal combination and 
minimal number of the candidate reference genes, respectively.
GeNorm. The GeNorm uses the geometric means to determine gene expression normalization factor and 
stability value (M) for each gene34. M values less than 1.5 are acceptable and the lowest values are considered most 
stable. Then, the software performs a pairwise comparison (Vn/n + 1) adding genes, one by one, in order to set 
the most stable reference genes until a cut-off less than 0.15 for determining the minimal number of the candidate 
reference genes8,11,34,38.
NormFinder. The NormFinder uses the standard curve or the delta-Ct method from the transformation of Ct 
(cycle threshold) values in a linear scale35. The program estimates the expression variation from candidate genes, 
providing a stability value (M) for each gene, and the variation between sample subgroups35. Similar to GeNorm, 
the lowest M values are considered most stable11,12,35.
7Scientific RepoRtS |         (2019) 9:16533  | https://doi.org/10.1038/s41598-019-52612-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
BestKeeper. The BestKeeper uses the geometric mean from candidate reference genes and the software 
provides a correlation coefficient (r) of each gene, besides to calculate standard deviation (SD) and coefficient 
of variation (CV) from the samples Ct-values36. It is recommended SD to be [±CP] < 1, SD [±x-fold] < 2 and 
correlation coefficient to be as higher as possible, close to the value 136,38. Low SD and CV associated to high cor-
relation coefficient (r) values indicate a stable reference gene, however the program does not perform a ranking 
order from the analyzed genes11,36. De Spiegelaere et al.12 highlighted that correlation coefficient (r) is a better 
parameter to assess the most stable genes than the standard deviation because the first one is able to analyze the 
correlation of each gene with the BestKeeper Index from the geometric mean from the studied reference genes. 
Thus we chose this measurement to evaluate and to perform the rank of reference genes in BestKeeper analysis.
RefFinder. The RefFinder is a web-based platform (http://fulxie.0fees.us/?type=reference) which integrates 
the three software packages abovementioned and additionally performs the comparative ∆∆Ct method12,37,39. The 
RefFinder only uses Cq (cycle quantification) to perform the reference genes rank through of geometric mean 
values (GM), without any possibility to include PCR efficiency12. Therefore, the RefFinder platform was used as 
complementary tool to assess reference gene stability.
Reference and target genes analysis. After the determination of optimal combination and minimal num-
ber of the candidate reference genes by software analysis, the most stable combination and the recommended can-
didate reference genes were used to perform the normalization from geometric media. To validate these potential 
reference genes, the IFNG was used as target gene (Table 1, SM 1). The selection of IFNG is due to the fact this 
cytokine is an immune-derived cytokine, with active roles in differentiation of osteoclasts and osteoblasts40.
conclusions
According to our results, we recommend the use of RPLP0 and B2M as the most stable reference genes to OP 
studies, as we showed their lower variation impact and influence on the evaluation of a target gene expression. 
On the other hand, we do not recommend the use of the least stable reference genes (HPRT1, 18 S and ACTB) in 
OP expression assays. Additionally, we emphasize a carefully choice of software packages to be used for reference 
gene selection. Finally, we highlighted that future studies should check the stability of the reference genes as other 
experimental methods and backgrounds of patients such as age and different cell sources. We suggest that, based 
on the present study, a smaller set of candidate reference genes herein showed may be used for similar analyses.
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